Latest in Weak Guidance
Sort by
100 items
-
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.Business - CNBC - 11 hours ago -
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.Business - CNBC - 18 hours ago -
Carvana raises 2024 earnings guidance after topping Wall Street's Q3 expectations
Carvana said its adjusted EBITDA would be "significantly above the high end" of its previous target of $1 billion to $1.2 billion.Business - CNBC - 10 hours ago -
We reiterate our 1 rating on Microsoft despite its softer guidance — here's why
The numbers look different this quarter due the company re-segmenting a few businesses, but overall there's not much to complain about.Business - CNBC - 6 hours ago